An individual displays a hand with tell-tale scarring of a historical burn event. Source: Adobe Stock
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

Avita Medical (ASX:AVH) has announced the US FDA has issued a premarket approval for its RECELL GO skin cell harvesting device.

The system allows patients requiring burns and wound treatment to see improved healing outcomes with less donor skin needed, and reportedly less pain.

In patients where burns were less than 50% of total body surface area, the system also led to less time in hospital beds, according to Avita.

The NASDAQ-dual-lister described RECELL GO as enhancing Spray-On Skin Cells (a registered product) with the potential to reduce burden on medical staff in emergency rooms and care wards.

The company also reports it has made it easier for medical staff to work with enzymes upon which the product relies.

The product will be launched in burn treatment centres in June.

“FDA approval of RECELL GO marks a shift in the treatment of partial-thickness and full- thickness wounds,” Avita CEO Jim Corbett said.

“We believe that this transformative shift will empower more clinicians to achieve optimal outcomes for their patients.”

AVH last traded at $2.66/sh.

avh by the numbers
More From The Market Online

Market Close: ASX slides 1.58% as global AI sell-off rattles investors

My nerves, along with my portfolio, have taken a beating over the last couple of weeks – and I’m sick of seeing red!

Market Close: Materials drag ASX lower as seven sectors finish higher

The Australian share market finished lower on Monday, with weakness across the resources sector weighing on the broader market despite gains across most

Market Close: ASX slides as resources and miners lead broad market sell-off

The Australian sharemarket came under renewed pressure on Tuesday 17th Nov, with selling extending across almost every sector as resources and energy

Market Close: ASX slides as technology and materials stocks lead broad market decline

The Australian share market finished lower on Wednesday, with the S&P/ASX 200 falling 0.69% to close at 8,821.80 points.